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Objectives: We sought to characterize the outcomes of routine catheterization prior
to superior cavopulmonary anastomosis and to determine if some patients were
unlikely to benefit from catheterization and thus might be evaluated preoperatively
with noninvasive methods alone.
Background: Congenital heart disease patients with single ventricle physiology
undergo routine echocardiography and cardiac catheterization prior to superior
cavopulmonary anastomosis to determine anatomic and hemodynamic suitability for
this procedure.
Methods: We performed a retrospective review of all infants (n 114) evaluated for
potential superior cavopulmonary anastomosis at our institution from January 1997
to June 2000.
Results: Patients’ median age was 5.5 months. Full echocardiograms were obtained
in 79 patients (69%). At catheterization a total of 41 interventions were performed
in 35 patients (31%). Twenty-seven patients (24%) were transfused, 18 patients
(17%) required cardiac intensive care unit admission, and median length of stay
following catheterization was 1 day (range 0 to 22). Complications occurred in 28
patients (25%), most transient. Of 51 patients who had complete echocardiograms
without indication for catheterization, none subsequently had significant interven-
tions and only 2 had new findings at catheterization. Three candidates were excluded
from operation; all 111 others underwent successful procedures and survived to
hospital discharge.
Conclusions: Interventions were frequent at catheterization prior to superior cavo-
pulmonary anastomosis, but transient complications, transfusion, intensive care unit
admission, and prolonged hospital length of stay were common. For patients in
whom no issues indicating need for catheterization are identified by echocardio-
gram, routine catheterization rarely results in new information or intervention.
These patients may be more safely evaluated preoperatively using exclusively
noninvasive techniques.
Current clinical practice for pediatric patients undergoing stagedpalliation of functional single ventricle includes echocardiographic(ECHO) evaluation as well as routine cardiac catheterization(CATH) prior to superior cavopulmonary anastamosis (SCPA),also known as bidirectional Glenn operation. Few published dataexist on the clinical utility of information obtained from pre-SCPA
ECHO and CATH evaluation. We sought to characterize the quality of the infor-
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mation obtained by ECHO and CATH; the interventions
performed at CATH; related outcomes including fluoros-
copy time, frequency of transfusion, intensive care unit
(ICU) admission, and hospital length of stay (LOS); as well
as the nature and extent of CATH complications. Finally,
we sought to determine whether a group might be identified
who were unlikely to benefit from CATH in terms of either
intervention or new diagnoses that might influence the sur-
gical management.
Methods
We reviewed the records of patients at our institution with single
ventricle physiology who were evaluated with ECHO and CATH
prior to SCPA during the 3-year period from January 1997 through
June 2000. Patients were identified by a search of the cardiology
and cardiac surgery databases.
Patients were excluded if their ECHO, CATH, or surgical
information was missing or unavailable. To minimize bias related
to institutional practice, patients were also excluded if either the
pre-SCPA ECHO (2 patients) or pre-SCPA CATH (6 patients) was
performed at a nonaffiliated hospital.
In addition to demographic information collected at the time of
CATH, medical records were reviewed for any prior diagnoses,
ECHOs, CATHs, and operative procedures. Ventricular type was
assigned based upon previously published criteria.1
For this study, the pre-SCPA ECHO data were obtained from
the official report of the staff echocardiographer who interpreted
the study without secondary review. For those with multiple
ECHOs, the study in closest temporal proximity prior to the
pre-SCPA CATH was selected as the pre-SCPA study. As is usual
in clinical practice, congenital anatomic diagnoses (ie, the pres-
ence or absence of bilateral superior vena cavae) based on prior
investigations or surgical observations were recorded and included
in the body of known facts at the time of pre-SCPA CATH.
Complete ECHOs were defined as those including assessments
of ventricular function, atrioventricular valve regurgitation, atrial
septum, aortic arch obstruction (both ascending and descending),
proximal branch pulmonary arteries, and pulmonary venous path-
ways. Distal arch obstruction, especially for those after aortic arch
reconstruction, was defined by Doppler flow velocities greater than
3 m/s in association with a greater than 50% reduction in lumen
diameter. Adequate imaging of the right pulmonary artery was
considered visualization to its passage behind the superior vena
cava; adequate imaging of the left pulmonary artery was consid-
ered visualization of 3 or more lumen diameters distal to its origin.
For this study, both the ECHO and CATH designations of mild,
moderate, or severe pulmonary artery (PA) stenosis were based
upon a visual estimate for stenosis in the context of the size of the
adjacent segment of unnarrowed pulmonary artery, with a mild
stenosis representing 25% narrowing, moderate stenosis 50%
narrowing, and severe stenosis 75% narrowing. The standard of
ventricular function used was a visual estimate of the ejection
fraction; mild dysfunction was an ejection fraction 50%, mod-
erate dysfunction 40%, and severe dysfunction 30% or less.
Atrioventricular valve regurgitation assessment was based upon
the width of the proximal regurgitation jet by color Doppler
relative to the size of the patient. Any limitations of the pre-SCPA
study, such as failed sedation or poor ECHO windows, were
recorded.
Pre-SCPA CATH data were taken from the official report of the
staff catheterizing cardiologist who interpreted the study, without
secondary review. For patients with more than 1 CATH, the
procedure immediately preceding SCPA was considered the pre-
SCPA CATH. In addition to hemodynamic data and calculations,
angiographic data and interventions were recorded. CATH, post-
CATH recovery, and hospital records were reviewed for fluoros-
copy time, blood product transfusions given, whether patients had
ICU admission, any other complications, and hospital LOS. For
those who remained in the hospital until their operation, the CATH
LOS was considered over on the day of the operation, as SCPA is
typically a same-day admission surgery at our institution. Compli-
cations were recorded and included arrhythmias (those requiring
treatment or significant enough to be listed in final CATH report),
acidosis (arterial pH  7.25), nonelective intubation, initiation of
intravenous inotropes in the CATH lab, chest compressions, as
well as other miscellaneous complications.
For the purposes of subsequent analysis, interventions were
categorized after review of angiograms by an interventional car-
diologist as either significant interventions or of uncertain signif-
icance (coil occlusion of tiny or small aortopulmonary collaterals
or venovenous collaterals was considered to be of uncertain sig-
nificance).
Statistical Analysis
Logistic regression was used to explore the relationship between
dichotomous outcome variables (any complications, any signifi-
cant intervention, need for transfusion, ICU admission) and pre-
CATH patient characteristics and ECHO information. Similarly,
linear regression was used for continuous outcome variables (hos-
pital LOS, fluoroscopy time). Because the continuous outcome
variables were not normally distributed, a log transformation was
used. Evaluation of the associations among the outcome variables
themselves was performed using Fisher’s exact test for 2 dichot-
omous outcomes (eg, to assess the relationship between compli-
cations and significant interventions), the Wilcoxon rank sum test
for 1 dichotomous and 1 continuous outcome, and the Spearman
rank correlation coefficient for the 2 continuous outcomes.
Results
A total of 114 patients underwent pre-SCPA evaluation
during the study period. Patient characteristics including
ventricular type, prior operations, prior CATH history, and
demographics and anthropometrics are listed in Table 1.
ECHO and CATH results are shown in Tables 2-5. Results
of pre-SCPA ECHO evaluation are listed in Table 2. Pa-
tients with incomplete ECHO evaluation were ascribed to
unsedated study (11), failed sedation (4), poor acoustic
windows (8), or simply incomplete study (12). Hemody-
namic results from CATH were notable for median pulmo-
nary arterial pressure of 17 mm Hg (range 9 to 30), with
median calculated pulmonary vascular resistance 2.3
Woods units/m2 (range 0.4 to 11.6); other CATH findings
are summarized in Table 3. Forty-one interventions were
performed in 35 patients (31%), summarized in Table 4.
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Complications of CATH are listed in Table 5. Of the 114
patients, 28 (25%) had at least 1 complication related to
CATH. There were no deaths, no neurologic sequelae or
strokes, no retroperitoneal bleeds, no surgical interventions
for bleeding, and no wound or bloodstream infections re-
lated to CATH in this cohort of patients. Additional surgical
procedures performed at the time of SCPA included PA
plasty in 25 patients, atrial septectomy in 9 patients, and
atrioventricular valve plasty in 5 patients.
Interventions
After review of relevant angiograms, interventions were
categorized as either significant or of uncertain significance;
the latter were limited to the coil occlusion of tiny or small
aortopulmonary or venovenous collaterals. Of the 35 pa-
tients with any intervention, 27 patients had significant
interventions.
In multivariable analysis, significant interventions were
more common in patients with coarctation or distal arch
obstruction by ECHO (odds ratio [OR] 3.6, P .02). The
relationship between ventricular type and intervention ap-
proached but did not achieve statistical significance, with
significant interventions more common in single RV pa-
tients (50% versus those with other ventricular types 21%,
P  .06).
Those with significant interventions had longer fluoros-
copy times (median 54 minutes versus 40 min, P  .04),
more frequent transfusions (48% vs 16%, P  .001), ICU
admissions (33% vs 11%, P  .02), complications (41% vs
20%, P  .04), and longer median hospital LOS (2 days vs
1 day, P  0.005). Patients with significant interventions or
new findings at catheterization had lower median weight for
age centile (4.1 vs 14.2, P .003) and lower median weight
z-score (1.7 vs 1.1, P  .003), but no significant dif-
ferences in height for age centile or z-score, weight for
height, saturation, or hemoglobin level.
Complications
As noted above, 28 of the 114 patients (25%) had at least 1
complication. In multivariable analysis of pre-CATH vari-
ables, patients who had any PA stenosis noted on ECHO
were more likely to have a complication (OR  2.9, P 
.01). In addition, patients without evidence of aortic ob-
TABLE 1. Patient characteristics (n  114)*
Ventricular type
Hypoplastic left heart syndrome 41 (36%)
Heterotaxy syndrome 20 (17%)
Single LV/NRGA 18 (16%)
Single LV/TGA 14 (12%)
Single right ventricle 10 (9%)
Other 11 (10%)
Prior operation
None 12 (11%)
Norwood/Stage I 54 (47%)
Modified Blalock-Taussig shunt 31 (27%)
Main pulmonary artery band 9 (8%)
RVOT patch with modified BT shunt 4 (3.5%)
TAPVR repair,  modified BT shunt 4 (3.5%)
Prior catheterization 35 (31%)
Age at catheterization (months) 5.5 (1.1–160)
Weight (kg) 6.0 (3.2–50)
Weight for age centile (%) 20.6 (0.2–99.3)
Weight for age z score (SD) 1.27 (4.68–1.70)
Height (cm) 63 (40.5–155.5)
Body surface area (m2) 0.33 (0.21–1.42)
Cutaneous saturation (%) 76 (55–90)
Hemoglobin (g/dL) 15.9 (10–20.5)
*Values listed are number (%) or median (range). LV, Left ventricle; NRGA,
normally related great arteries; TGA, transposed great arteries; RVOT, right
ventricular outflow tract; BT, Blalock-Taussig; TAPVR, totally anomalous
pulmonary venous return.
TABLE 2. Echocardiographic findings
Finding evaluated
Patients
evaluated Details
Complete
echocardiogram
79 (69%) See text
Ventricular
function
114 (100%) Good function—88 (77%)
Mild dysfunction—11 (10%)
Mod dysfunction—10 (9%)
Severe dysfunction—5 (4%)
Systemic AV
valve
regurgitation
113 (99%) No/trivial AVVR—66 (58%)
Mild AVVR—31 (28%)
Mod AVVR—14 (12%)
Severe AVVR—2 (2%)
Atrial septum 106 (93%) Restrictive/intact—9 (8%)
Proximal arch
obstruction
104 (91%) Arch obstruction—2 (2%)
Distal arch
obstruction
92 (81%) Arch obstruction—17 (18%)
Left pulmonary
artery
83 (73%) Mild LPA stenosis—12 (14%)
Right pulmonary
artery
86 (75%) Mild RPA stenosis—14 (16%)
Both pulmonary
arteries
83 (73%) Mild PA stenosis—24 (29%)
Presence
bilateral SVC
113 (99%) Bilateral SVC—25 (22%)
Pulmonary
venous
obstruction
113 (99%) Mild single PV obst.—1 (1%)
Unilateral PV atresia—2 (2%)
Stenosis PV confluence—1 (1%)
Severe stenosis mult PVs—2 (2%)
Mod, Moderate; AV, atrioventricular; AVVR, atrioventricular valve regurgi-
tation; PA, pulmonary artery; LPA, left pulmonary artery; RPA, right pulmo-
nary artery; SVC, superior vena cava; PV, pulmonary vein; obst, obstruc-
tion; mult, multiple.
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struction (proximal or distal) by ECHO were less likely to
have a complication (OR  0.22, P  .001).
Fluoroscopy Time
Median fluoroscopy time for this group of patients was 44
minutes, with a range of 13 to 220 minutes. In multivariable
analysis, prior operation was the only significant predictor
of fluoroscopy time, with patients with prior Stage I Nor-
wood procedure having shorter fluoroscopy times than those
with other procedures or no prior operation (P  .001).
Transfusions
Of the 114 patients, 27 (24%) received a blood transfusion.
In multivariable analysis, a higher cutaneous saturation was
the best predictor of transfusion (OR  2.0 for each 10%
increase in saturation, P  .06). However, no relationship
was observed with baseline hemoglobin level and transfu-
sion.
ICU Admissions
Of the 114 patients, 18 (17%) were admitted to the cardiac
ICU following catheterization. However, 2 of the 18 pa-
tients were ICU inpatients prior to catheterization (1 venti-
lator-dependent and the other intravenous inotrope-depen-
dent). In multivariable analysis, patients with severe
ventricular dysfunction by ECHO were more likely to have
an ICU admission (OR 12.5, P .01). In particular, 60%
of patients with severe ventricular dysfunction required ICU
admission. Patients with prior Stage I Norwood procedure
were less likely to require ICU admission (OR  0.27, P 
.03).
Length of Hospital Stay
Median LOS was 1 day, with range from 0 to 22 days. In
multivariable analysis, patients with severe ventricular dys-
function by ECHO had longer hospital LOS (median 6 days
for those with severe ventricular dysfunction, P  .001).
Patients Excluded from SCPA Operation
During the 3.5-year period of the study, 3 patients who
underwent pre-SCPA evaluation were excluded from
SCPA. All excluded patients had heterotaxy syndrome, 2
had severe stenoses of multiple individual pulmonary veins,
and the third patient had severe bilateral PA hypoplasia. All
TABLE 3. Catheterization findings
Finding evaluated
Patients
evaluated Details
Atrial septum 114 (100%) Restrictive/intact—8 (7%)
Proximal arch
obstruction
114 (100%) Arch Obstruction—4 (3.5%)
Distal arch
obstruction
114 (100%) Arch Obstruction—14 (12%)
Left pulmonary
artery
114 (100%) Mild LPA stenosis—15 (13%)
Moderate LPA stenosis—4 (4%)
Severe LPA stenosis—2 (2%)
No flow to LPA—1 (1%)
Right pulmonary
artery
114 (100%) Mild RPA stenosis—16 (14%)
Moderate RPA stenosis—5 (4%)
Severe RPA stenosis—1 (1%)
Both pulmonary
arteries
114 (100%) Mild PA stenosis—39 (34%)
Presence bilateral
SVC
108 (95%) Bilateral SVC—26 (24%)
Pulmonary venous
obstruction
114 (100%) Obstruction/atresia—6 (5%)
Venovenous
collaterals
108 (95%) Tiny/small collaterals—6 (5%)
Aortopulmonary
collaterals
112 (99%) Small collaterals—10 (9%)
PA, Pulmonary artery; LPA, left pulmonary artery; RPA, right pulmonary
artery; SVC, superior vena cava; PV, pulmonary vein.
TABLE 4. CATH Interventions
Type
Number of
patients
Any intervention 35 (31%)
Significant interventions* 27
Balloon dilation aortic obstruction 10
Coil venovenous collaterals 10
Coil aortopulmonary collaterals 7
Hemodynamic testing (balloon occlusion, NO/O2) 6
Pulmonary artery dilation 3
Pulmonary vein dilation 2
ASD creation/balloon dilation 2
Balloon dilation pulmonary valve 1
*See text for definition of nonsignificant interventions. NO, nitric oxide, O2,
oxygen; ASD, atrial septal defect.
TABLE 5. CATH Complications
Type Number of patients
Any complication 28 (25%)
Arrhythmia (sustained or requiring treatment) 7
Acidosis (arterial pH  7.25) 15
Nonelective intubation 8
Initiation IV inotropes 3
CPR/chest compressions 2
Other complications
Severe hypertension requiring treatment 2
Loss of femoral arterial pulse 2
Clot in modified BT shunt 1
Retained wire fragment 1
Large pelvic hematoma 1
Emergent transfer to OR (cyanosis) 1
IV, Intravenous; CPR, cardiopulmonary resuscitation; BT, Blalock-Taussig;
OR, operating room.
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3 patients were correctly identified by ECHO as having
significant issues requiring CATH.
Comparison of ECHO and CATH data
Patients were divided into subgroups based on the results of
the pre-SPCA ECHO evaluation according to the complete-
ness of ECHO study and suspected issues requiring CATH
evaluation. Patients were also divided into 1 of 3 categories
according to the results of the pre-SCPA CATH: those with
no intervention or new findings, those with interventions of
uncertain significance, and those with significant interven-
tions or new findings. Figure 1 presents the results of this
analysis. Of the 51 patients who had a complete ECHO and
in whom there were no suspected issues requiring CATH
evaluation, only 2 patients had the unsuspected finding of
pulmonary artery stenosis and underwent surgical arterio-
plasty at the time of SCPA, and no patients had a significant
intervention during the CATH.
Procedure-related outcomes in this subgroup of 51 pa-
tients included a mean fluoroscopy time of 44 minutes, 5
transfusions (10%), 7 admissions to the ICU (14%), and 10
CATH-related complications (20%).
A similar analysis for patients with hypoplastic left heart
syndrome is presented in Figure 2. Although fewer of these
patients had a complete ECHO (25 of 41 patients, 61%), of
the 14 patients in whom no issues requiring CATH were
identified by ECHO, no patients had a significant interven-
tion at CATH.
Discussion
Over the past 2 decades, with the advent of 2-dimensional
and Doppler echocardiography and refinements in ultra-
sound technology, the role of hemodynamic CATH in the
routine preoperative evaluation of patients with congenital
heart disease has been steadily decreasing. In 1984, Freed
and colleagues2 demonstrated that routine CATH was un-
necessary prior to repair of secundum and sinus venosus
atrial septal defect; 4 years later, Lipshultz and colleagues3
showed the same was true for ostium primum atrial septal
defect. A growing body of literature testifies to the success
of surgery following noninvasive evaluation alone for se-
lected cardiac lesions.4-7
However, for patients requiring single ventricle pallia-
tion, in particular SCPA and Fontan operation, routine pre-
operative CATH is still standard of care in many institu-
tions, including our own. In addition to providing an
assessment of pulmonary arterial and venous architecture
and pulmonary vascular resistance, CATH assists in evalu-
ating systemic outflow tract and arch obstruction. Moreover,
catheter-based interventions such as balloon dilation of aor-
tic arch obstruction have proven useful adjuncts to the
surgical care of such patients.
In this retrospective review we examined the evaluation
of pre-SCPA candidates to characterize the quality of the
information obtained by ECHO and CATH, the interven-
tions performed at CATH, and any associated morbidity.
Finally, we attempted to define patients who are unlikely to
benefit from CATH in terms of either intervention or change
in the planned surgical procedure.
Preoperative ECHO Adequacy
Although our definition of complete ECHO assessment
was fairly demanding, this was performed in nearly 70%
of pre-SCPA candidates. Due to the expense, inconve-
nience, and risk of sedation, incomplete preoperative
echocardiographic assessment is often accepted based on
the knowledge that a catheterization is planned prior to
surgery. Because study limitations in the remaining pa-
tients were frequently ascribed to either unsedated or
failed sedation patients, it is likely that additional pa-
tients could have had a complete evaluation with better
planning, preparation, and the assistance of the anesthe-
sia staff with difficult sedations. Only 8 patients had poor
ECHO windows cited as a study limitation, and for these
patients, clearly other methods of preoperative evaluation
would have been necessary.
For those with inadequate ECHOs, evaluation of the
aortic arch and the branch pulmonary arteries were the
portions most often missed and presumably the most diffi-
cult to image. The aortic arch was assessed in 81% of
patients, and both branch pulmonary arteries in 73%. In this
diverse group of patients, ECHO had a sensitivity of 100%
for aortic arch obstruction; however, it falsely predicted
coarctation not confirmed at CATH in three patients (all
hypoplastic left heart syndrome [HLHS] patients after Stage
I Norwood). This result differs somewhat from prior pub-
lished reports suggesting ECHO is specific but of limited
sensitivity for aortic arch obstruction for patients after Stage
I Norwood procedure.8 However, our sample size of HLHS
patients was smaller and it may be reasonable to assume that
HLHS patients present difficulties in arch evaluation for
ECHO and may require other methods of preoperative arch
evaluation.
Branch PA assessment was successful in 73% of patients
on the pre-SCPA ECHO. For those patients in whom the
branch PAs were successfully evaluated by ECHO, agree-
ment with CATH assessment occurred 82% of the time. In
the remaining 18%, lack of agreement was due to a disparity
of 1 grade; for example, moderate stenosis by ECHO and
mild by CATH. In only 2 cases did ECHO fail to detect PA
stenosis in patients who later had PA plasty at the time of
SCPA. Both of these patients had undergone prior Stage I
Norwood procedure, indicating again that this group of
patients may benefit from further preoperative evaluation.
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Figure 1. Echocardiogram and catheterization data by subgroup analysis. *For definition of complete ECHO, see
“Methods.” †Significant interventions defined in “Methods.” PA, Pulmonary artery; pulm, pulmonary; mod, moder-
ate; LSVC, left superior vena cava.
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Post-CATH Outcomes and Complications
For patients who do not have interventions performed during
the pre-SCPA CATH, improved preoperative diagnosis may
avoid the need for CATH and therefore catheterization-related
complications. For example, although few published data exist
on radiation exposure in routine pediatric cardiac CATH,9,10
and no data exist on the pre-SCPA CATH in particular. The
median fluoroscopy time was 44 minutes in the two thirds of
patients who did not have intervention at CATH, a significant
exposure in a population likely to undergo multiple CATHs.
In addition, transfusions were common, occurring in
24% of patients. Although transfusions among patients who
Figure 2. Echocardiogram and catheterization subgroup analysis for patients with hypoplastic left heart syndrome.
*For definition of complete ECHO, see “Methods.” †Significant interventions defined in “Methods.” PA, Pulmonary
artery; pulm, pulmonary; mod, moderate; LSVC, left superior vena cava.
Surgery for Congenital Heart Disease Brown et al
278 The Journal of Thoracic and Cardiovascular Surgery ● July 2003
CH
D
had interventions performed were frequent, nearly half of
the transfusions (12 of 27) occurred in those who had no
intervention performed. We are unaware of any published
series documenting the rate of transfusion after CATH in a
comparable group of patients. Although a relationship of
borderline significance was observed with higher cutaneous
saturation and transfusion, which suggested that those with
lower hemoglobin values were more likely to be transfused,
baseline hemoglobin and transfusion proved to have no
significant relationship in this group of patients.
Eighteen patients (17%) required cardiac ICU admission
with an increased risk in those with severe ventricular
dysfunction (odds ratio 12.5, P  .01). Median LOS fol-
lowing CATH was 1 day (range 0 to 22) and was signifi-
cantly longer for those with severe ventricular dysfunction
(P  .001). Clearly, patients with severe ventricular dys-
function are high-risk CATH patients, and noninvasive
methods of evaluation may be even more desirable for this
subgroup, especially given that half of the patients in this
subgroup had no intervention at CATH.
Complications occurred in 25% of pre-SCPA candidates,
although most were transient, and there was no associated
mortality. Several series on pediatric CATH have been
published in the last 2 decades, with complication rates
ranging from 1.5% to 25%.11-16 Young age at CATH, low
body weight, and interventional procedures have been es-
tablished as risk factors for complications,17-19 all of which
were common in this group of patients, with a mean age of
5.5 months and a mean weight of 6.0 kg. However, half of
the patients who had complications (15 of 31 patients) did
not have an intervention performed at CATH.
Significance of CATH Interventions
Although the importance of performing an intervention
during the pre-SCPA CATH is at times uncertain, it never-
theless influences the retrospective assessment as to whether
the CATH was necessary. Overall, interventions were per-
formed in 31% of our patients, with the most common
intervention being balloon dilation of the aortic arch (10
patients). This number reflects the high proportion of pa-
tients after Stage I Norwood procedure in our study, in
whom a documented propensity for distal arch obstruction
has been described20 and in whom balloon dilation of the
arch was most commonly performed. Other interventions
that we classified as important in this analysis included coil
occlusion of moderate or large aortopulmonary or veno-
venous collaterals, as well as hemodynamic testing with
oxygen or nitric oxide to assess pulmonary vascular reac-
tivity. In contrast, we classified the coil occlusion of small
venovenous or aortopulmonary collaterals as “interventions
of uncertain significance” that may have no demonstrable
benefit to the patient and would not solely constitute a clear
justification for the procedure. Although frequently these
interventions were accompanied by other “significant” in-
terventions, for some patients these were the only interven-
tion performed.
Venovenous collaterals after SCPA can be a cause of
cyanosis, with the elevation in superior vena caval pressures
presumably leading to the enlargement of existing veno-
venous connections. Magee and colleagues21 found that
nearly a third of their patients developed venous collaterals
after SCPA, and development of such vessels was associ-
ated with higher mean gradient between superior vena cava
and right atrium. However, no study has examined the
impact of coil occlusion of such vessels on morbidity after
SCPA, short or long term; and furthermore, tiny or small
venovenous collaterals that become larger after SCPA could
ostensibly be effectively coiled prior to Fontan operation at
lower risk due to patient growth.
Aortopulmonary collaterals have long been suspected to
contribute to postoperative morbidity, presumably due to
the excess volume load incurred on the single ventricle
circulation. However, to date no controlled prospective
studies have addressed this issue.22 Indeed, several recent
retrospective studies have documented that the presence of
aortopulmonary collaterals in Fontan patients has had no
impact on postoperative hemodynamics, duration of effu-
sions, duration of tube thoracostomy, or resource utilization
after the Fontan procedure.23,24 Therefore, based on the
available data, the coil occlusion of small aortopulmonary
collaterals is not known to have an effect on postoperative
outcomes and may be considered of questionable value.
Identification of Patients Unlikely to Benefit From
Catheterization
For assessments of AV valve regurgitation, ventricular
function, and the status of the atrial septum, ECHO is
generally accepted as an excellent modality alone in guiding
surgical decision making; this has been demonstrated in the
literature for many forms of congenital heart disease.2-6 In
this series, hemodynamic and angiographic CATH assess-
ments of ventricular function, for example, were frequently
not performed (40%); the same is true for AV valve regur-
gitation. Five patients underwent AV valve plasty at time of
SCPA, each of whom had either moderate or severe AV
valve regurgitation by ECHO. In this series, CATH did not
provide new information on either ventricular function or
AV valve regurgitation. The atrial septum was visualized
well in nearly all patients by ECHO, and when seen, had a
perfect correlation with catheterization data. In 2 cases, the
atrial septum was dilated, but in both cases this was a
temporizing measure prior to surgical atrial septal defect
creation at time of SCPA, and the necessity of this as an
intervention itself may be questionable, although in this
review this was included as a significant intervention. Fur-
thermore, in all 9 cases where atrial septectomy was per-
formed at the time of SCPA, ECHO correctly identified the
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atrial septum as restrictive or intact. Pulmonary artery ste-
noses were accurately documented by ECHO prior to
CATH in nearly all patients; in the 25 patients who had PA
plasty performed at the time of SCPA, 23 of these had mild
or greater branch PA stenoses identified by ECHO. These
stenoses were rarely intervened on at catheterization (3
patients), and thus in this series were not a reason for
catheterization when the pulmonary arteries can be imaged
noninvasively.
When patients were categorized into those with a com-
plete ECHO and no suspected issues requiring CATH (51
patients, or 48% of our study group), only 2 patients had
significant unsuspected findings (both Stage I Norwood
patients with pulmonary artery stenosis who had pulmonary
arterioplasty at the time of SCPA) and no patients subse-
quently had a significant intervention at CATH. Forty-two
patients had no intervention, and 7 had interventions of
uncertain significance as discussed previously. Furthermore,
this group of patients was not free from morbidity; in
addition to mean fluoroscopy times of 44 minutes, 5 of the
27 transfusions, 7 of 18 ICU admissions, and 10 of the 31
complications occurred in this subgroup of patients. It is
difficult to ascertain whether the identification of unsus-
pected PA stenosis in 2 of 51 patients was clinically impor-
tant to the achievement of a successful postoperative out-
come; however, the diagnostic yield of new findings in this
group seems low, especially in light of the high rate of
CATH-related morbidity and the potential ability to estab-
lish such a diagnosis either intraoperatively or by other
noninvasive tests such as cardiac MRI.
Importantly, of the 3 patients excluded from SCPA based
upon the pre-SCPA evaluation, all were correctly identified
on ECHO as having important risk factors requiring CATH
(2 patients with pulmonary vein stenosis and 1 patient with
severely hypoplastic pulmonary arteries). The remaining
111 patients underwent successful SCPA and survived to
hospital discharge.
Study Limitations
As a retrospective review of patients referred for pre-SCPA
evaluation, this study is prone to all the biases inherent in
such studies. In particular, it is quite difficult to discern
retrospectively the precise clinical indications for some out-
comes, such as transfusion or ICU admission; as clinical
decisions, it is possible that some of these may reflect forms
of institutional bias. In addition, outcomes such as fluoros-
copy time may be affected by the status of our institution as
a teaching hospital, and perhaps not generalizable to other
non-teaching venues.
Furthermore, as this study did not examine postoperative
outcomes beyond survival to hospital discharge, no conclu-
sions regarding CATH data and postoperative management
and other outcomes (such as duration of postoperative ICU
stay) are possible, and knowledge of CATH data may have
improved such outcomes for these patients. In addition, due
to the retrospective nature of this study, how the surgical
plan may have changed prior to and following ECHO and
CATH can only be inferred.
Implications
Complete ECHO evaluation prior to SCPA can successfully
identify a subgroup of patients in whom no issues are
identified requiring CATH evaluation or intervention;
CATH rarely benefits these patients and is associated with
significant morbidity. Two patients after Stage I Norwood
who had pulmonary arterioplasty at time of surgery were
missed in this group of patients by ECHO evaluation alone,
suggesting that pre-SCPA CATH may be indicated in all
patients with this diagnosis. Alternatively, magnetic reso-
nance imaging may represent an excellent noninvasive al-
ternative to routine CATH and would provide anatomic
information on branch and distal pulmonary arteries and
pulmonary veins, as well as proximal and distal arch anat-
omy.25
Interventions were often performed as part of pre-SCPA
CATH, but transient complications, transfusion, ICU ad-
mission, and prolonged hospital LOS were common in this
high-risk group of patients regardless of whether or not an
intervention was performed. We conclude that patients who
have evidence of aortic arch or pulmonary venous obstruc-
tion, significant aortopulmonary or venovenous collaterals,
or for whom hemodynamic testing is warranted should
continue to be catheterized, as well as those with inadequate
noninvasive imaging of the aortic arch, pulmonary arteries,
pulmonary veins, atrial septum, or AV valve regurgitation.
For selected patients in whom no issues requiring CATH are
identified by ECHO, routine CATH rarely results in new
information or intervention, and these patients may be more
safely evaluated with noninvasive techniques prior to
SCPA.
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